Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025202 (
melanoma
)
69,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A sensitive in situ melanin assay using cultured mouse B16
melanoma
cells is described for structure-activity studies with
melanocyte-stimulating hormone (MSH)
peptides. B16 Cells were seeded at a density of 2500 cells per well in 96-well microtest tissue culture plates; after 24 h the cells were incubated in the presence of serial dilutions of MSH peptides for 3 to 5 days. The melanin released into the medium of each well was then determined spectrophotometrically at a wavelength of 405 nm using an automatic microplate reader calibrated against synthetic melanin. Studies with
alpha-MSH
, [Nle4, D-Phe7]-
alpha-MSH
, [3'-iodo-Tyr2]-
alpha-MSH
,
adrenocorticotropin
(ACTH)(1-24), and ACTH(1-39) showed that the peptides had identical intrinsic activities and that the relative potencies were similar to those obtained with a tyrosinase assay. The EC50 of
alpha-MSH
was 27 pM, i.e., about five- to sevenfold lower than that in the assays for tyrosinase or intracellular melanin. Thus, the new assay represents the most sensitive
melanoma
cell assay for MSH available to date.
...
PMID:In situ melanin assay for MSH using mouse B16 melanoma cells in culture. 381 99
alpha-Melanocyte-stimulating hormone (
alpha-MSH
, alpha-melanotropin), [Nle4,D-Phe7]-
alpha-MSH
and related fragment analogues, Ac-[Nle4,D-Phe7]-alpha-MSH4-11-NH2 and Ac-[Nle4,D-Phe7]-alpha-MSH4-10-NH2, were studied for their ability to stimulate tyrosinase activity in Cloudman S91 mouse
melanoma
cells in tissue culture. All of the melanotropins stimulated tyrosinase activity in a dose-dependent manner. [Nle4,D-Phe7]-
alpha-MSH
was about 100 times more active than
alpha-MSH
as determined from the minimal effective dose (MED) required to activate the enzyme above control (basal) levels. The MED of this analogue to significantly stimulate tyrosinase activity at 24, 48 and 72 h of incubation was 10(-11) M whereas the MED of
alpha-MSH
was 10(-9) M at each of these times. The maximum tyrosinase activity achieved from the time of initial incubation in the presence of [Nle4,D-Phe7]-
alpha-MSH
was approximately 3-, 5- and 6-fold greater than control levels at 24, 48 and 72 h, respectively. The 2 [Nle4,D-Phe7]-substituted fragment analogues were at least as active as the tridecapeptide analogue and therefore at least 100-fold more active than
alpha-MSH
in stimulating enzyme activity. These [Nle4,D-Phe7]-substituted analogues were more active in the
melanoma
tyrosinase assay than in the
melanoma
adenylate cyclase assay or other normal melanocyte (frog and lizard skin) bioassays.
...
PMID:Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins. 392 59
A spontaneous cyclic phenomenon characterized by successive waves of either high proliferative rate or intense melanogenesis is described in non-confluent B16
melanoma
cells subcultivated during 2 months (or more). Dopaoxidase activity is quantified in individual cells after L-dopa reaction, by an original method of visible light absorption cytophotometry. A 24-hr treatment with
alpha-MSH
increases dopa-oxidase activity. This increase is also noted during the following 14 hr, in a fresh medium devoid of
alpha-MSH
, in which cell proliferation resumes after 24 hr. Phenylthiourea, cycloheximide or actinomycin D inhibit dopaoxidase activity, but also cell proliferation in
alpha-MSH
pre-stimulated cells. The effects of the two latter agents suggest that de novo synthesis of the enzyme takes place following
alpha-MSH
treatment.
...
PMID:Quantitative cytochemical analysis by microdensitometry of spontaneous or alpha-MSH-stimulated melanogenesis in B16 melanoma cells cultivated in vitro. 393 Feb 53
Highly purified synthetic salmonid melanin concentrating hormone (MCH) and some analogs were investigated for their ability to concentrate the pigment in scale melanophores of the Chinese grass carp, Ctenopharyngodon idellus, to produce melanin dispersion in frog or lizard melanophores and to inhibit
alpha-MSH
in its action on mouse
melanoma
and rat adrenal glomerulosa cells in vitro. In the grass carp, MCH produced half-maximal pigment aggregation at 6 X 10(-11) M and its oxidized form at 7 X 10(-11) M. Replacement of the two methionines at position 3 and 6 with norvaline lowered the potency by a factor of 2.7 and with propargylglycine by a factor of about 7. Linear, Cys5,14-Acm-protected MCH was a full agonist of MCH but with a 345-fold lower potency. Iodinated MCH showed similar, low activity. In tetrapods, salmonid MCH and its analogs displayed only marginal pigment dispersion at concentrations greater than 10(-5) M. Alkali-treatment of MCH increased the pigment-dispersing potency by a factor of about 30 whereas the activity for pigment aggregation in the grass carp was destroyed. At high concentrations (10(-6), 10(-5) M) MCH also stimulated tyrosinase activity in B-16 mouse
melanoma
cells but did not modify the effects of
alpha-MSH
in this system. By contrast, when tested on rat adrenal glomerulosa cells, salmonid MCH had no effect alone but at a concentration of greater than 10(-10) M it slightly reduced corticosterone production by an
alpha-MSH
concentration of 10(-7) M. Aldosterone production was not affected and MCH did not influence the response to ACTH.
...
PMID:Effect of melanin concentrating hormone on pigment and adrenal cells in vitro. 393 41
The antitumor action of the 2-chloroethylnitrosocarbamoyl derivatives of peptides related to the 9-13 amino acid residues of
alpha-MSH
/ACTH and of the C-terminal tetrapeptide analogue of gastrin have been investigated. Series of 2-chloroethylnitrosoureas attached to amino acids, di-, tri-, tetra-, or pentapeptides were examined in a primary screening system. Among these compounds the Pro-Val-, Lys-Pro-Val-, and Trp-Gly-Lys-Pro-Val-containing 2-chloroethylnitrosocarbamoyl groups were the most effective in the L1210 system. The human
melanoma
xenograft line was also affected by these agents, while colorectal xenografts were insensitive. A combination of tripeptide-2-chloroethyl-nitrosourea with BCNU induced more than additive growth inhibition of L1210 leukemia.
...
PMID:Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments. 394 98
Transglutaminase (TGase; R-glutaminyl-peptide:amine gamma-glutamyltransferase, EC 2.3.2.13) and ornithine decarboxylase (ODCase; L-ornithine carboxy-lyase, EC 4.1.1.17) activities were measured after the addition of retinoid analogs to Chinese hamster ovary (CHO) cells released from quiescence and Cloudman S91 (CCL 53.1) mouse
melanoma
cells stimulated to differentiate with
alpha-melanocyte-stimulating hormone
(MSH, melanotropin). In both cell culture lines, we detected a biphasic increase in TGase activity and a single peak of ODCase activity within 7 hr after release or stimulation. Retinoid analogs altered the expression of the initial TGase peak in both CHO and
melanoma
cells. Retinol increased the activity of TGase 1 hr after release in CHO cells, and the activity remained elevated until hr 4. A broad peak of TGase activity also occurred after the addition of alpha-difluoromethylornithine, an irreversible inhibitor of ODCase, and after addition of alpha-difluoromethylornithine plus retinol. In mouse
melanoma
cells, retinoic acid plus MSH markedly enhanced the activity of the initial TGase peak compared to MSH alone. Retinoic acid alone also increased TGase activity biphasically in these cells without the addition of MSH. These studies suggest that retinoid effects that increase TGase activity may alter the ODCase expression in proliferation and differentiation.
...
PMID:Retinoids increase transglutaminase activity and inhibit ornithine decarboxylase activity in Chinese hamster ovary cells and in melanoma cells stimulated to differentiate. 612 41
Adrenocorticotropic hormone
(
ACTH
) and mouse but not human interferon caused a steroidogenic response and induced antiviral activity in mouse adrenal tumor (Y-1) cells.
ACTH
and human but not mouse interferon caused induction of melanin synthesis and antiviral activity in human
melanoma
cells.
ACTH
did not induce antiviral activity in mouse L or human amnion (WISH) cells. The hormonal activities of interferon were neutralized by specific rabbit anti-interferon sera. Thus, interferon has species-specific hormonal activity and
ACTH
has cell-specific antiviral activity. These results are discussed in terms of the possible natural functions of interferon polypeptide hormones.
...
PMID:Interferon and adrenocorticotropic hormone induction of steroidogenesis, melanogenesis and antiviral activity. 616 39
Retinoic acid was found to be a potent stimulant of pigmentation in human Hs939
melanoma
cells. Exposure to 1 microM retinoic acid for longer than four days caused both a decrease in the rate of cell proliferation and a concomitant increase in melanogenesis. These effects of retinoic acid progressed lin-early in a time-dependent and a dose-dependent fashion such that at the end of a seven-day treatment cell growth was inhibited by approximately 65%, and both melanin content and tyrosinase activity increased more than three-fold over the control. Interpolation of the dose-response curves indicated that 3 nM retinoic acid would cause half-maximal melanogenesis stimulation. No elevation in the level of cyclic adenosine 3':5'-monophosphate could be detected in the
melanoma
cells following various periods of exposure to retinoic acid, and the cells were unresponsive to
alpha-melanocyte-stimulating hormone
. In the presence of the tyrosinase inhibitor phenylthiocarbamate, retinoic acid was capable of inhibiting cell proliferation without enhancing melanin synthesis. The tumor promoter phorbol myristate acetate did not affect either the proliferation or the differentiation of the Hs939
melanoma
cells. However, the enhancement of melanogenesis by 1 microM retinoic acid was inhibited by 66% in the presence of 0.1 microM phorbol myristate acetate. The tumor promoter did not reverse the growth-inhibitory effect of retinoic acid. Phorbol, a non-tumor promoter, was effective. Other retinoids, such as 13-cis-retinoic acid, retinyl acetate, nd the trimethylmethoxyphenyl analog of retinoic acid, also inhibited the proliferation and enhanced melanin production in the Hs939 cells. In contrast, retinyl palmitate, the phenyl analog of retinoic acid, and the pyridyl analog of retinoic acid were ineffective.
...
PMID:Stimulation of melanogenesis in a human melanoma cell line by retinoids. 625 61
Synthetic
alpha-melanocyte-stimulating hormone
(
alpha-MSH
) was found to bind to the plasma membrane of the HM6A human
melanoma
cell line, using an immunocytochemical method. When treated with 10(-7) to 10(-9) M
alpha-MSH
,
melanoma
cells exhibited an increase of intracellular cyclic adenosine 3':5'-monophosphate, followed by stimulation of tyrosinase activity. Significant inhibition of DNA synthesis measured by [3H]thymidine uptake and inhibition of cell growth was found. A retrovirus expression was detected in the supernatant of HM6A cells as assayed by the KC cell syncytium-forming test. In he presence of 10(-7) M
alpha-MSH
, the number of syncytium-forming units was increased 15-fold. These results demonstrate that
alpha-MSH
modulates human
melanoma
differentiation and virus expression in vitro.
...
PMID:alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line. 626 Mar 42
The ability of alpha-melanotrophin (
alpha-MSH
or ACTH 1-acetyl-13 amide) and other structurally related peptides derived from the common precursor, pro-opiocortin, to stimulate adenylate cyclase activity in a pigmented B16 mouse
melanoma
was investigated. The peptides ACTH 1-39, ACTH 1-24,
alpha-MSH
, ACTH 1-13 amide and
beta-MSH
all stimulated the enzyme to a similar maximal extent and with similar potency (ED50 = 1.3 . 10(-6) M) except that ACTH 1-39 was slightly less potent (ED50 = 5 . 10(-6) M). ACTH 4-10 (ED50 = 4 . 10(-5) M) and
gamma-MSH
(ED50 = 5 . 10(-6) M) were partial agonists. ACTH 1-10 was no more effective than ACTH 4-10 in stimulating the enzyme whereas ACTH 1-13 amide was a full agonist. The peptides
beta-endorphin
and its derivatives, Met-enkephalin and melanotrophin potentiating factor (MPF), failed to stimulate the enzyme. We suggest that the B16
melanoma
requires not only the sequence ACTH 4-10 but also some part of the sequence ACTH 11-13, or a similar sequence in the terminal portion of
beta-MSH
, for full activation of the receptor-linked enzyme.
...
PMID:Stimulation of the adenylate cyclase of A B16 melanoma cell line by pro-opiocortin-related peptides--a structure-activity study. 626 82
<< Previous
1
2
3
4
5
6
7
8
9
10